ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,700Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 2094

$1.1M Total Retail Price of All Prescriptions

Rank: 70 out of 2094

552 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 13,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 591 559 1 1
LEVOTHYROXINE SODIUM 502 462 2 3
AMLODIPINE BESYLATE 416 408 3 2
FUROSEMIDE 396 376 4 6
MIRTAZAPINE 356 349 5 43
WARFARIN SODIUM 341 291 6 11
DONEPEZIL HCL 295 290 7 20
OMEPRAZOLE 290 271 8 4
LISINOPRIL 276 260 9 7
NAMENDA 263 258 10 32
DIVALPROEX SODIUM 245 243 11 69
METOPROLOL TARTRATE 242 232 12 10
ATORVASTATIN CALCIUM 232 219 13 5
METOPROLOL SUCCINATE 219 218 14 9
POTASSIUM CHLORIDE 209 179 15 24
RISPERIDONE 162 157 16 56
TRIAMTERENE-HCTZ 159 149 17 87
ZOLPIDEM TARTRATE 146 146 18 14
HYDROCHLOROTHIAZIDE 144 141 19 12
TAMSULOSIN HCL 143 132 20 29
DIGOXIN 140 140 21 51
PANTOPRAZOLE SODIUM 130 101 22 37
METFORMIN HCL 127 125 23 8
MELOXICAM 123 118 24 49
FAMOTIDINE 122 109 25 34
LEVOFLOXACIN 119 115 26 70
LOSARTAN POTASSIUM 118 117 27 17
FENTANYL 115 112 S2 28 68
SERTRALINE HCL 110 110 29 26
QUETIAPINE FUMARATE 106 106 30 71
DIOVAN 104 104 31 13
AMLODIPINE BESYLATE-BENAZEPRIL 102 98 32 58
LEVETIRACETAM 99 68 33 78
GLIMEPIRIDE 98 96 34 31
CELEBREX 97 97 35 74
ENALAPRIL MALEATE 95 95 36 25
NEXIUM 94 59 37 16
LIDODERM 90 77 38 59
SPIRONOLACTONE 90 89 38 93
ALENDRONATE SODIUM 90 71 38 30
CITALOPRAM HBR 86 86 41 47
CLOPIDOGREL 85 65 42 22
LIPITOR 85 83 42 39
OXYCODONE-ACETAMINOPHEN 82 60 S2 44 40
CYMBALTA 82 64 44 61
ATENOLOL 82 82 44 21
CARVEDILOL 81 74 47 19
GABAPENTIN 81 72 47 23
ALBUTEROL SULFATE 78 25 49 90
PRAVASTATIN SODIUM 78 72 49 18
RAMIPRIL 75 72 51 48
ESCITALOPRAM OXALATE 74 71 52 46
DIOVAN HCT 74 70 52 28
METFORMIN HCL ER 69 69 54 67
SILVER SULFADIAZINE 67 51 55 281
LATANOPROST 64 52 56 153
EXELON 64 64 56 111
BACLOFEN 63 40 58 166
LYRICA 62 62 59 85
AZITHROMYCIN 61 58 60 27
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 60 52
TRAMADOL HCL 57 57 62 33
OLANZAPINE 57 57 62 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 55 64 55
FINASTERIDE 56 56 64 97
POLYETHYLENE GLYCOL 3350 55 53 66 75
BENAZEPRIL HCL 55 55 66 154
LANTUS 55 41 66 66
DILTIAZEM 24HR CD 54 51 69 110
ALLOPURINOL 54 54 69 50
LUNESTA 54 54 69 293
CRESTOR 53 42 72 15
NOVOLOG 53 50 72 116
EVISTA 52 52 74 131
SINGULAIR 51 46 75 64
CARBIDOPA-LEVODOPA 51 51 75 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.